Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 33, 2019 - Issue 19
160
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis and biological evaluation of picroside derivatives as hepatoprotective agents

, , , , , & show all
Pages 2845-2850 | Received 12 Apr 2018, Accepted 30 Jul 2018, Published online: 08 Nov 2018

References

  • Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, Thanacoody RH, Gray AJ, Webb DJ, Moggs JG. 2013. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology.58: 777–787.
  • Cao Y, Liu JW, Yu YJ, Zheng PY, Zhang XD, Li T, Guo MC. 2007. Synergistic protective effect of picroside II and NGF on PC12 cells against oxidative stress induced by H2O2. Chinese Journal of Clinical Pharmacology & Therapeutics.59:573.
  • Duval F, Moreno-Cuevas JE, González-Garza MT, Rodríguez-Montalvo C, Cruz-Vega DE. 2014. Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells. Advances in Pharmacological Sciences.2014: 373295.
  • Fontana RJ. 2014. Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives. Gastroenterology.146: 914–928.
  • Ghabril M, Bonkovsky HL, Kum C, Davern T, Hayashi PH, Kleiner DE, Serrano J, Rochon J, Fontana RJ, Bonacini M. 2013. Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases. Clinical Gastroenterology & Hepatology.11: 558–564.e553.
  • Guo Y, Xu X, Li Q, Li Z, Du F. 2010. Anti-inflammation effects of picroside 2 in cerebral ischemic injury rats. Behavioral & Brain Functions.6: 43.
  • Holt MP, Ju C. 2014. Mechanisms of drug-induced liver injury. Current Opinion in Allergy & Clinical Immunology.14: 286–292.
  • Hussaini SH, Farrington EA. 2014. Idiosyncratic drug-induced liver injury: an update on the 2007 overview. Expert Opinion on Drug Safety.13: 67–81.
  • Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, Reddy KR, Seeff LB, Serrano J, Sherker AH. 2014. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology.60: 1399–1408.
  • Rathee D, Thanki M, Bhuva S, Anandjiwala S, Agrawal R. 2013. Iridoid glycosides-Kutkin, Picroside I, and Kutkoside from Picrorrhiza kurroa Benth inhibits the invasion and migration of MCF-7 breast cancer cells through the down regulation of matrix metalloproteinases: 1st Cancer Update. Arabian Journal of Chemistry.6: 49–58.
  • Schaub JR, Malato Y, Gormond C, Willenbring H. 2014. Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury. Cell Reports.8: 933–939.
  • Subeq YM, Ke CY, Lin NT, Lee CJ, Chiu YH, Hsu BG. 2011. Valsartan decreases TGF-Î21 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats. Cytokine.53: 223–230.
  • Wang L, Liu X, Chen H, Chen Z, Weng X, Qiu T, Liu L. 2015. Effect of picroside II on apoptosis induced by renal ischemia/reperfusion injury in rats. Experimental & Therapeutic Medicine.9: 817–822.
  • Wang L, Liu XH, Chen H, Chen ZY, Weng XD, Qiu T, Liu L. 2014. Picroside II decreases the development of fibrosis induced by ischemia/reperfusion injury in rats. Renal Failure.36: 1443–1448.
  • Wu N, Li W, Shu W, Jia D. 2014. Protective effect of picroside II on myocardial ischemia reperfusion injury in rats. Drug Design Development & Therapy.2014: 545–554.
  • Zhang B, Guo X, Chen J, Jiang H, Cardiology DO. 2016. The protective effect of picroside-II in myocardial ischemia/reperfusion injury and its mechanism. Journal of Clinical Cardiology.9: 952–956.
  • Zhen LI, Xin-Ying XU, Shen W, Guo YL. 2010. The interferring effects of picroside II on the expressions of NF-κB and I-κB following cerebral ischemia reperfusion injury in rats. Chinese Pharmacological Bulletin.1: 52–56.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.